Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Short Interventions to Prevent Trapezius Muscle Fatigue in Computer Work

1 mars 2019 mis à jour par: Swiss Federal Institute of Technology

Trapezius Muscle Fatigue of Long Duration: a Likely Neuromuscular Control Issue

This study is expected to demonstrate that during experimental days of seated computer work sustained and focalized low-level muscle activity contributes to the development of long-lasting fatigue effects (and thus possible disorder). On days with and without frequent interruptions, signs of fatigue and the activity pattern of the trapeze muscle are registered and compared using electromyographic registrations of the trapezius muscle.

Aperçu de l'étude

Statut

Complété

Description détaillée

30 healthy adults without chronic neck pain participated in a laboratory study designed to simulate two full workdays of computer work. Within each session, participants performed five 50-min working activities separated by 10-min breaks: i) Use a computer keyboard to type a text presented on the left side of the screen; ii) do the typing task with the desk height set10 cm above elbow height; iii) play the computer game Spider Solitaire implemented in Windows 10; iv) Stroop test (This test consists of reading the name of a color whose text is in a color different from the name. The color name was then selected from a multiple-choice panel displaying color names; v) the same online puzzle game was presented to all participants. Assembling the puzzle was performed by drag and drop actions. The work periods were not disrupted (on the "control day") whereas two short interruptions of 5-min were introduced at 1/3 and 2/3 of each working period on the "intervention day". During these interruptions, participants were asked to perform "muscle disrupting/relaxing" activities. For each experimental session a 30-min lunch break took place between the third and the fourth work periods. The specific sequence of work activity type and disrupting/relaxing activities was randomized across participants; however, for each participant the order of work activities remained the same for the two experimental sessions (control and intervention days). The order of control and intervention days was also randomized between participants.

A set of six measures were performed at specific time intervals during each experiment: before the first work activity, before and after lunch, immediately and 1 hour after the fifth (last) work activity: i) upper trapezius activation, assessed through the temporal EMG profile recorded by a single bipolar signal; and ii) through the spatio-temporal distribution of EMG activity detected by a 2D array of electrodes (64 channels); iii) muscle fatigue, quantified by changes in electrically induced muscle twitch force signals, iv) isometric performance, v) dynamic performance; iii) cognitive and physical load and stress level. In addition, personality traits (anxiety level), perceived workload and musculoskeletal symptoms were evaluated as covariates.

Type d'étude

Interventionnel

Inscription (Réel)

30

Phase

  • N'est pas applicable

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 40 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • healthy experienced computer workers

Exclusion Criteria:

  • chronic pain (more than 30 days within the last 12 months according to the Nordic Questionnaire (Kuorinka et al 1987);
  • pathologies of the neck,
  • prior and actual shoulder or neck pain caused by an accident,
  • skin disease in the neck or shoulder area,
  • BMI > 30,
  • sleep disorders (e.g. apnea, restless legs syndrome),
  • use of medications such as psychotropic drugs, muscle relaxants or analgesics within the last 3 days prior to the experiment,
  • pregnancy.
  • any shoulder/neck pain on the day before the experiment.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Modèle interventionnel: Affectation séquentielle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: short interruptions of work tasks
randomly start with or without short interruptions on the first experimental day and without or with them on the second experimental day

During each activity two interruptions/breaks were selected randomly from a set of ten predetermined actions:

Active break types:

  • Move shoulder and upper back
  • Swing arms near the body
  • Three slow but forceful elevations of the shoulders, a relaxation exercise based on the principles developed by Jacobson
  • Stand up and stretch
  • Slowly turn head in all possible directions.

Passive break types:

  • Tell a couple of jokes
  • Stand up and have a drink
  • Relaxing the trapezius
  • Questions on actual posture and feelings of comfort / discomfort.
  • A short rest on the couch

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
EMG profile recorded by a single bipolar electrode: Rest-time
Délai: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Rest-time (percentage of time below 5% of the standard activity level). The percentage of registration time without any rest time is called sustained low level muscle activity.
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Area of muscle activity
Délai: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined:

Area of muscle active region (n. of channels)

Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of muscle twitch
Délai: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
3-D muscle twitch acceleration pattern measured at the acromion
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of dynamic force control accuracy
Délai: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in an isometric dynamic tracking task
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
EMG profile recorded by a single bipolar electrode: Static activity
Délai: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
p10 (level of the 10th percentile of the trapezius muscle activity) as an indicator of static activity primarily associated with continuous activity of the same pool of motor units.
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Magnitude of activity
Délai: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined:

Magnitude of activity of muscle active regions (RMS sEMG).

Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Number of active epochs
Délai: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Number of active epochs
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of static force control
Délai: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric isotonic low level contraction
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of force control in ramp contraction
Délai: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric ramp contraction.
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Localized musculoskeletal discomfort
Délai: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
head-neck-shoulders-lower back-elbows-wrists-hip-upper legs-knees-ankles-feet-discomfort rated on 10 cm visual analog scales (adapted from Nordic questionnaire (Kuorinka et al 1987)
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
Visual and general fatigue
Délai: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
10 cm visual analog scales
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
Effort
Délai: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
6-20 Borg scale (6= no effort, 20=maximal possible effort)
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
EMG profile recorded by a single bipolar electrode: Dynamic activity
Délai: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
p90 (level of the 90th percentile of the trapezius muscle activity) as an indicator of dynamic activity which may promote variability in the recruitment of motor units
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Centroid of active regions
Délai: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Centroid of active regions
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Thomas Läubli, MD, Federal Institute of Technology Zurich

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

14 mars 2016

Achèvement primaire (Réel)

5 septembre 2016

Achèvement de l'étude (Réel)

5 septembre 2016

Dates d'inscription aux études

Première soumission

14 décembre 2018

Première soumission répondant aux critères de contrôle qualité

1 mars 2019

Première publication (Réel)

5 mars 2019

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

5 mars 2019

Dernière mise à jour soumise répondant aux critères de contrôle qualité

1 mars 2019

Dernière vérification

1 février 2019

Plus d'information

Termes liés à cette étude

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • 32003B_160207

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner